Yahoo Web Search

Search results

1. • Small Business - Salisbury Post | Salisbury Post

     The Salisbury Post· 7 days ago

     ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug Candidates PR Newswire SUZHOU, China and ROCKVILLE, Md., May 23, 2024 SUZHOU, China and ROCKVILLE, Md., May 23, 2024 /PRNewswire/ -- Ascentage Pharma

2. • 

     The ASCO Annual Meeting Starts Next Week in Chicago

     Medscape· 6 days ago

     About 45,000 people will descend on Chicago next week, starting on May 31 to June 4, for the American Society of Clinical Oncology (ASCO) annual meeting....

3. • Rigel Announces Presentations at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress

     WROC Rochester· 7 days ago

     Oral presentation of final five-year results from the registrational Phase 2 trial in R/R mIDH1 AML patients reinforces REZLIDHIA® (olutasidenib) efficacy in heavily pretreated patients, including ...

4. • 

     South Carolina parts ways with longtime men's golf coach Bill McDonald

     Golf Channel via Yahoo Sports· 7 days ago

     “If I’m sitting on the back porch with a fire going thinking about the good ol’ days, it was that...

5. • Small Business - The Andalusia Star-News | The Andalusia Star-News

     The Andalusia Star-News· 20 hours ago

     Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven ...

6. • Deciphering Unexpected Vascular Locations of Scedosporium spp. and Lomentospora prolificans Fungal...

     Centers for Disease Control and Prevention· 7 days ago

     We describe an underrecognized Scedosporium spp. and Lomentospora prolificans vascular tropism requiring specific management of which clinicians should be aware.

7. • 

     All over the body: Here are the key clinical trials from Bay Area firms - San Francisco Business...

     The Business Journals· 6 days ago

     Since the turn of the millennium, Bay Area organizations and researchers have launched more than 300...

8. • Tenax Therapeutics, Inc. Forecasted to Earn Q2 2024 Earnings of ($1.72) Per Share (NASDAQ:TENX)

     ETF DAILY NEWS· 7 days ago

     Tenax Therapeutics, Inc. (NASDAQ:TENX – Free Report) – Equities researchers at Zacks Small Cap cut their Q2 2024 earnings per share (EPS) estimates for shares of Tenax Therapeutics in a report ...

9. • Bristol-Myers Squibb (NYSE:BMY) Shares Down 1.1%

     ETF DAILY NEWS· 5 days ago

     Shares of Bristol-Myers Squibb (NYSE:BMY – Get Free Report) fell 1.1% during trading on Thursday . The company traded as low as $41.58 and last traded at $41.89. 3,501,801 shares changed hands ...

10. • Incyte (NASDAQ:INCY) Coverage Initiated at Deutsche Bank Aktiengesellschaft

      ETF DAILY NEWS· 6 days ago

      Equities research analysts at Deutsche Bank Aktiengesellschaft began coverage on shares of Incyte (NASDAQ:INCY – Get Free Report) in a research note issued to investors on Thursday, MarketBeat ...